Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis

NCT02092467 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

4372

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: tofacitinib
DRUG: tofacitinib
BIOLOGICAL: adalimumab
BIOLOGICAL: etanercept

Sponsor

Pfizer